Literature DB >> 30551494

The cardiac electrophysiology effects of higenamine in guinea pig heart.

Yuhong Wang1, Jing Geng2, Min Jiang2, Cong Li1, Yanxing Han1, Jiandong Jiang3.   

Abstract

BACKGROUND: Higenamine (HG) is an active compound derived from Aconiti root with a cardiotonic effect. It has been approved by the Chinese SFDA for clinical trials due to its effect as a potent inotropic and chronotropic agent in the heart. However, the direct mode of action of HG on cardiac electrophysiology is unclear.
METHODS: The experiments were performed at both cell levels and the isolated organ. The major cardiac ion currents and the action potential duration (APD) were measured using patch-clamps in single guinea-pig left ventricular myocytes. ECG was recorded in isolated guinea pig hearts.
RESULTS: In the left ventricular myocytes, HG increased ICa-L and IKs in concentration- and voltage-dependent manners in the left ventricular myocytes. It potentiated the ICa-L and IKs simultaneously for synchronization. The EC50 values were 0.27 μM and 0.64 μM for the ICa-L and IKs, respectively. HG (0.1 μM, 0.5 μM and 1 μM) had no effect on the IKr and INa. HG slightly prolonged APD at lower concentrations, and shortened the APD at higher concentrations. HG can induce the delayed after depolarization (DAD), which showed some pro-arrhythmic effect. In the isolated perfused heart, HG increased the heart rate via an action on the sinoatrial node cells, but did not induce cardiac arrhythmias, even at high concentrations. The EC50 value for the sinoatrial node that controls the heart rate was 0.13 μM. The sinoatrial node cells appeared to be more sensitive than ventricular myocytes to HG. The effects of HG on ventricular cells and sinoatrial node cells were both mediated through stimulation of β1-AR.
CONCLUSION: We show for the first time that HG produced a predominant action on the sinoatrial node. HG appears to control the cardiac electrophysiology through its predominant effect on the sinoarial node cells, without induction of the ectopic activity that causes cardiac arrhythmias. Thus, HG might be useful for the treatment of bradycardia.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Action potential duration (APD); Cardiac electrophysiology; Higenamine; Ion channels; β-Adrenergic receptor

Mesh:

Substances:

Year:  2018        PMID: 30551494     DOI: 10.1016/j.biopha.2018.10.022

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

Review 1.  Not Just from Ethanol. Tetrahydroisoquinolinic (TIQ) Derivatives: from Neurotoxicity to Neuroprotection.

Authors:  Alessandra T Peana; Valentina Bassareo; Elio Acquas
Journal:  Neurotox Res       Date:  2019-05-02       Impact factor: 3.911

2.  Therapeutic effects of higenamine combined with [6]-gingerol on chronic heart failure induced by doxorubicin via ameliorating mitochondrial function.

Authors:  Jianxia Wen; Lu Zhang; Jian Wang; Jiabo Wang; Lifu Wang; Ruilin Wang; Ruisheng Li; Honghong Liu; Shizhang Wei; Haotian Li; Wenjun Zou; Yanling Zhao
Journal:  J Cell Mol Med       Date:  2020-02-19       Impact factor: 5.310

Review 3.  Role of Higenamine in Heart Diseases: A Mini-Review.

Authors:  Jianxia Wen; Mingjie Li; Wenwen Zhang; Haoyu Wang; Yan Bai; Junjie Hao; Chuan Liu; Ke Deng; Yanling Zhao
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

Review 4.  Pharmacological effects of higenamine based on signalling pathways and mechanism of action.

Authors:  De-Ta Chen; Wu Rao; Xue Shen; Lin Chen; Zi-Jian Wan; Xiao-Ping Sheng; Tian-You Fan
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

5.  Use of liquid chromatography-tandem mass spectrometry for determination of higenamine in urine following oral administration of traditional Chinese medicine.

Authors:  Chengjun Guo; Ning Zhang; Xiaoli Zhang; Mingfeng Chi; Dongren Liu; Jing Zhang
Journal:  Drug Test Anal       Date:  2022-05-03       Impact factor: 3.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.